Condition: Post Stroke Depression · Sponsor: Assaf-Harofeh Medical Center
The study evaluates the effect of HBOT on depression in patients suffering from persistent symptoms of post stroke depression (PSD) in an double blind sham control study.
This description comes directly from the study's public registry record.
Shai a Efrati, MD · 972549212866 · efratishai@outlook.com
Always discuss trial participation with your own doctor first.
| The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh) | Zrifin, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07423273